The Regulatory Effect of Insulin-Like Growth Factor-2 on Hypothalamic Gonadotropin-Releasing Hormone Neurons during the Pubertal Period

Background: The insulin-like growth factor (IGF) system plays a vital role in regulating gonadotropin-releasing hormone (GnRH), whether the IGF2 can act on the GnRH neurons during the pubertal period is unclear. Methods:...

Full description

Bibliographic Details
Published in:	Journal of Integrative Neuroscience
Main Authors:	Xiaoli Dai, Yuanyuan He, Xinghui Han, Wen Sun, Jian Yu, Yating Lin, Yonghong Wang
Format:	Article
Language:	English
Published:	IMR Press 2024-11-01
Subjects:	gonadotropin-releasing hormone insulin-like growth factor 2 central precocious puberty gt1-7
Online Access:	https://www.imrpress.com/journal/JIN/23/11/10.31083/j.jin2311208

Similar Items

Effect of gonadotropin-releasing hormone agonist treatment on near final height in girls with central precocious puberty and early puberty
by: Eun Hye Yang, et al.
Published: (2023-03-01)

The genes associated with gonadotropin-releasing hormone-dependent precocious puberty
by: Jin Soon Hwang
Published: (2012-01-01)

Clinical findings influencing time to menarche post gonadotropin-releasing hormone agonist therapy in central precocious puberty
by: Vickie Wu, et al.
Published: (2021-09-01)

Long-term effects of gonadotropin-releasing hormone analogs in girls with central precocious puberty
by: Eun Young Kim
Published: (2015-01-01)

Relationship between final adult height and birth weight after gonadotropin-releasing hormone agonist treatment in girls with central precocious puberty
by: Ah Young Cho, et al.
Published: (2020-03-01)

The Effect of Gonadotropin-releasing Hormone Analog Treatment on Body Mass Index and Height in Female Patients with Central Precocious Puberty
by: Muammer Büyükinan, et al.
Published: (2019-03-01)

The influence of gonadotropin releasing hormone agonist treatment on the body weight and body mass index in girls with idiopathic precocious puberty and early puberty
by: Sung Woo Kim, et al.
Published: (2017-06-01)

Gonadotropin dependent premature pubertal development in girls. Description of clinical cases
by: A. V. Vitebskaya, et al.
Published: (2017-03-01)

Comparison of the effect of gonadotropin-releasing hormone agonist dosage in girls with central precocious puberty
by: Shinyoung Jang, et al.
Published: (2023-02-01)

Adult height in girls with central precocious puberty treated with gonadotropin-releasing hormone agonist with or without growth hormone
by: Mo Kyung Jung, et al.
Published: (2014-12-01)

Short-term efficacy of 1-month and 3-month gonadotropin-releasing hormone agonist depots in girls with central precocious puberty
by: Min Jin Jeon, et al.
Published: (2021-09-01)

The Side Effects of Gonadotropin Releasing Hormone Analog (Diphereline) in Treatment of Idiopathic Central Precocious Puberty
by: Zohreh Karamizadeh, et al.
Published: (2013-01-01)

Gonadotropin-dependent pubertal disorders are common in patients with virilizing adrenocortical tumors in childhood
by: Monica F Stecchini, et al.
Published: (2019-05-01)

Comparing adult height gain and menarcheal age between girls with central precocious puberty treated with gonadotropin-releasing hormone agonist alone and those treated with combined growth hormone therapy
by: Min Sub Kim, et al.
Published: (2019-06-01)

Effect of gonadotropin-releasing hormone agonist therapy on body mass index and growth in girls with idiopathic central precocious puberty
by: Ahmet Anik, et al.
Published: (2015-01-01)

Effectiveness of the triptorelin stimulation test compared with the classic gonadotropin-releasing hormone stimulation test in diagnosing central precocious puberty in girls
by: Yu Jin Kim, et al.
Published: (2024-04-01)

Machine Learning Approach for Prediction of the Test Results of Gonadotropin-Releasing Hormone Stimulation: Model Building and Implementation
by: Yu-Shao Chen, et al.
Published: (2023-04-01)

중추성 성조숙증의 진단과 치료
Published: (2021-10-01)

Long-term outcomes of gonadotropin-releasing hormone agonist treatment in girls with central precocious puberty
by: Jung Hwangbo, et al.
Published: (2025-02-01)

Is precocious puberty linked to hypothalamic expression of arginine-phenylalanine-amide-related peptide?
by: Yuanyuan He, et al.
Published: (2017-10-01)

Longitudinal follow-up to near final height of auxological changes in girls with idiopathic central precocious puberty treated with gonadotropin-releasing hormone analog and grouped by pretreatment body mass index level
by: Jongho Park, et al.
Published: (2018-03-01)

Challenges and controversies in diagnosis and management of gonadotropin dependent precocious puberty: An Indian perspective
by: Manoj Kumar, et al.
Published: (2015-01-01)

Exploration of the molecular mechanism of modified Danggui Liuhuang Decoction in treating central precocious puberty and its effects on hypothalamic-pituitary-gonadal axis hormones
by: Xiaqing Liu, et al.
Published: (2025-04-01)

Gonadotropin-releasing hormone analog therapies for children with central precocious puberty in the United States
by: Jadranka Popovic, et al.
Published: (2022-10-01)

Etiology and therapeutic outcomes of children with gonadotropin-independent precocious puberty
by: Eungu Kang, et al.
Published: (2016-09-01)

Efficacy of combined gonadotropin-releasing hormone analogue and growth hormone therapy in girls with central precocious puberty: a systematic review and meta-analysis
by: Sufeng Jin, et al.
Published: (2025-10-01)

Efficacy and Safety of Domestic Leuprorelin in Girls with Idiopathic Central Precocious Puberty: A Multicenter, Randomized, Parallel, Controlled Trial
by: Wen-Jing Li, et al.
Published: (2015-01-01)

Elevated Pre-injection Basal Luteinizing Hormone Concentrations are Common in Girls Treated for Central Precocious Puberty
by: Stefanie Schubert, et al.
Published: (2021-06-01)

Gonadotropin-releasing hormone analogue and recombinant human growth hormone treatment for idiopathic central precocious puberty in girls
by: Yuzhen Shi, et al.
Published: (2022-12-01)

Treatment with Depot Leuprolide Acetate in Girls with Idiopathic Precocious Puberty: What Parameter should be Used in Deciding on the Initial Dose?
by: Doğuş Vurallı, et al.
Published: (2020-03-01)

Role of Gonadotropin-releasing Hormone Stimulation Test in Diagnosing Gonadotropin Deficiency in Both Males and Females with Delayed Puberty
by: Qi-Hong Sun, et al.
Published: (2015-01-01)

The value of urinary gonadotropins in the diagnosis of central precocious puberty: a meta-analysis
by: Dan Xu, et al.
Published: (2022-07-01)

A review on effects of agrochemicals on hypothalamic gonadotropin-releasing hormone neuron-pituitary gonadotropic reproductive axis
by: Yanping RUAN, et al.
Published: (2026-03-01)

The role of urinary LH and FSH in the diagnosis of pubertal disorders
by: Manoranjan Tripathy, et al.
Published: (2021-01-01)

Long-term efficacy of a triptorelin 3-month depot in girls with central precocious puberty
by: Kyu Hyun Park, et al.
Published: (2024-06-01)

Clinical data and basal gonadotropins in the diagnosis of central precocious puberty in girls
by: Teodoro Durá-Travé, et al.
Published: (2021-03-01)

Impact of 6-month triptorelin formulation on predicted adult height and basal gonadotropin levels in patients with central precocious puberty
by: Eunjoo Yoo, et al.
Published: (2023-02-01)

Effect of GnRH Analog Therapy on Adult Height in Girls with Idiopathic Central Precocious Puberty
by: Reiko Saito, et al.
Published: (2025-04-01)

Diagnostic evaluation of central precocious puberty in girls
by: Shu-Nin Yeh, et al.
Published: (2021-03-01)

Diagnostic value of urinary luteinizing hormone levels in the monitoring of precocious puberty treatment
by: Özge Yüce, et al.
Published: (2020-03-01)